CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 438 enrolled
Drug / intervention
Pharmacist-Driven Interventionbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03709277
NCT03709277N/ACompleted
CompareCT.gov

Patient-tailored Interventions to Improve Specialty Medication Adherence: Results From a Prospective Randomized Controlled Trial

Vanderbilt University Medical Center·interventional·Posted Oct 17, 2018·Updated Dec 1, 2023

In Brief

A clinical study evaluating Pharmacist-Driven Intervention for Adherence, Medication and Nonadherence, Medication. Completed, enrolled 438 participants across 1 site.

Detailed Summary

Patients deemed nonadherent to their specialty medications will be randomized to receive 8 months of patient-tailored adherence interventions and follow up from a specialty pharmacist as needed or the standard of care. Medication adherence will be measured using proportion of days covered (PDC) at 8-months post-randomization to determine if the intervention improved specialty medication adherence.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAdherence, Medication, Nonadherence, Medication
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedOct 17, 2018
Enrollment StartMay 10, 2019
Primary CompletionFeb 10, 2021
Study CompletionApr 10, 2022
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 7.7 years ago

Interventions

Pharmacist-Driven Interventionbehavioral

The pharmacist will investigate patient assistance options for patients who cannot afford their specialty medication, reach out to prescribers when needed to address intolerance/adverse effects, improve health literacy, recommend options for forgetfulness, make every effort to reach patient, address clinical and financial barriers to unresponsiveness (lack of lab completion, not returning to clinic, etc.)